Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Crooks

Showing results (131-140 of 319) with videos related to

Pageof 32
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
The characterization of a novel rigid nicotine analog with alpha7-selective nAChR agonist activity and modulation of agonist properties by boron inclusionRoger L Papke, Guangrong Zheng, Nicole A Horenstein, et al.
The AAPS Journal|December 16, 2005
Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the alpha4beta2 nicotinic acetylcholine receptor subtype using nonlinear techniquesJoshua T Ayers, Aaron Clauset, Jeffrey D Schmitt, et al.
Journal of Neurochemistry|July 24, 2013
GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamineDavid B Horton, Justin R Nickell, Guangrong Zheng, et al.
Behavioural Pharmacology|September 2, 2017
Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in ratsMegan M Kangiser, Linda P Dwoskin, Guangrong Zheng, et al.
Advances in Pharmacology (San Diego, Calif.)|February 4, 2014
The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuseJustin R Nickell, Kiran B Siripurapu, Ashish Vartak, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slicesLincoln H Wilkins, Aaron Haubner, Joshua T Ayers, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
(E,E)-1-Methyl-2,6-distyrylpyridinium iodideNarsimha Reddy Penthala, Joshua Eldridge, Thirupathi Reddy Yerram Reddy, et al.
Journal of Medicinal Chemistry|August 21, 2009
Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2)Ashish P Vartak, Justin R Nickell, Jaturaporn Chagkutip, et al.
Bioorganic & Medicinal Chemistry|May 30, 2009
QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatumFang Zheng, Matthew J McConnell, Chang-Guo Zhan, et al.
Bioorganic & Medicinal Chemistry|March 8, 2013
Improving the inhibitory activity of arylidenaminoguanidine compounds at the N-methyl-D-aspartate receptor complex from a recursive computational-experimental structure-activity relationship studyJoshua R Ring, Fang Zheng, Aaron J Haubner, et al.
Pageof 32

Showing results (131-140 of 319) with videos related to

Sort By:
Pageof 32
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
The characterization of a novel rigid nicotine analog with alpha7-selective nAChR agonist activity and modulation of agonist properties by boron inclusionRoger L Papke, Guangrong Zheng, Nicole A Horenstein, et al.
The AAPS Journal|December 16, 2005
Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the alpha4beta2 nicotinic acetylcholine receptor subtype using nonlinear techniquesJoshua T Ayers, Aaron Clauset, Jeffrey D Schmitt, et al.
Journal of Neurochemistry|July 24, 2013
GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamineDavid B Horton, Justin R Nickell, Guangrong Zheng, et al.
Behavioural Pharmacology|September 2, 2017
Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in ratsMegan M Kangiser, Linda P Dwoskin, Guangrong Zheng, et al.
Advances in Pharmacology (San Diego, Calif.)|February 4, 2014
The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuseJustin R Nickell, Kiran B Siripurapu, Ashish Vartak, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slicesLincoln H Wilkins, Aaron Haubner, Joshua T Ayers, et al.
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
(E,E)-1-Methyl-2,6-distyrylpyridinium iodideNarsimha Reddy Penthala, Joshua Eldridge, Thirupathi Reddy Yerram Reddy, et al.
Journal of Medicinal Chemistry|August 21, 2009
Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2)Ashish P Vartak, Justin R Nickell, Jaturaporn Chagkutip, et al.
Bioorganic & Medicinal Chemistry|May 30, 2009
QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatumFang Zheng, Matthew J McConnell, Chang-Guo Zhan, et al.
Bioorganic & Medicinal Chemistry|March 8, 2013
Improving the inhibitory activity of arylidenaminoguanidine compounds at the N-methyl-D-aspartate receptor complex from a recursive computational-experimental structure-activity relationship studyJoshua R Ring, Fang Zheng, Aaron J Haubner, et al.
Pageof 32